Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H19NO2 |
Molecular Weight | 209.2848 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCNCC(O)C1=CC=C(O)C=C1
InChI
InChIKey=RDUHXGIIUDVSHR-UHFFFAOYSA-N
InChI=1S/C12H19NO2/c1-2-3-8-13-9-12(15)10-4-6-11(14)7-5-10/h4-7,12-15H,2-3,8-9H2,1H3
Molecular Formula | C12H19NO2 |
Molecular Weight | 209.2848 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Bamethan (butyl-sympatol or vasculat) is an adrenaline derivative developed by C. H. Boehringer Sohn. Bamethan shows a depressor action on peripheral blood vessels as a result of the peripheral vasodilating action caused by stimulation of adrenergic beta-receptor. Bamethan has been used abroad in the treatment of certain peripheral vascular and circulatory disturbances, such as vasospastic conditions, arteriosclerotic peripheral vascular disease, Raynaud's syndrome, occlusive vascular disease of the legs, the post-thrombotic syndrome, degenerative muscular disorders, and other conditions involving peripheral vascular insuffciency.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The effect of bamethan on cardiovascular response. | 1966 Jan-Feb |
|
Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum. | 2002 Jun 20 |
|
Tandem mass spectrometry with online high-flow reversed-phase extraction and normal-phase chromatography on silica columns with aqueous-organic mobile phase for quantitation of polar compounds in biological fluids. | 2005 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Oct 22 06:10:16 UTC 2019
by
admin
on
Tue Oct 22 06:10:16 UTC 2019
|
Record UNII |
Y08ZFJ9TFK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QC04AA31
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
||
|
NCI_THESAURUS |
C48149
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
||
|
WHO-ATC |
C04AA31
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1321
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | RxNorm | ||
|
C76116
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
223-043-9
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
3703-79-5
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
BAMETHAN
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
3703-79-5
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
2292
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
M2217
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | Merck Index | ||
|
SUB06096MIG
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
995
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
C084810
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY | |||
|
CHEMBL1987462
Created by
admin on Tue Oct 22 06:10:16 UTC 2019 , Edited by admin on Tue Oct 22 06:10:16 UTC 2019
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |